Citius Oncology, Inc. ("Citius Oncology") , the oncology-focused subsidiary of Citius Pharmaceuticals, Inc. ("Citius Pharma") , today announced the commercial launch of LYMPHIRtm (denileukin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback